logo
Select company
Select metric
58.25%Gross Profits to Assets
VS
Market
91
Sector
90
Industry
94
History
100
$ 27.8Close
$ 13.49 - $ 27.89 52-Week Range
Ticker Information

Ticker

TVTX

Company Name

TRAVERE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRAVERE THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TVTX - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 555.31M$ 323.49M58.25%
3/31/2025$ 548.8M$ 262.61M47.85%
12/31/2024$ 594.13M$ 225.43M37.94%
9/30/2024$ 504.41M$ 193.69M38.4%
6/30/2024$ 551.12M$ 168.23M30.52%
3/31/2024$ 663.55M$ 173.88M26.2%
12/31/2023$ 788.91M$ 133.79M16.96%
9/30/2023$ 832.85M$ 199.52M23.96%
6/30/2023$ 736.43M$ 215.54M29.27%
3/31/2023$ 808.23M$ 209.94M25.98%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRAVERE THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 27.19%.
  • Over the past 5 years, TRAVERE THERAPEUTICS INC's average GPA has been 30.77%.
  • The median GPA for TRAVERE THERAPEUTICS INC during this period was 28.3%
  • TRAVERE THERAPEUTICS INC reached its highest GPA over the past 5 years at 58.25%.
  • The lowest GPA recorded by TRAVERE THERAPEUTICS INC in the same timeframe 16.96%

TRAVERE THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
IMCR : IMMUNOCORE HOLDINGS PLC 32.66%TARS : TARSUS PHARMACEUTICALS INC 55.74%INVA : INNOVIVA INC 24.04%VCEL : VERICEL CORP 42.02%MNKD : MANNKIND CORP 54.9%ARQT : ARCUTIS BIOTHERAPEUTICS INC 66.6%AUPH : AURINIA PHARMACEUTICALS INC 46.33%MDXG : MIMEDX GROUP INC 101.78%ARDX : ARDELYX INC 70.15%ADPT : ADAPTIVE BIOTECHNOLOGIES CORP 27.29%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for TRAVERE THERAPEUTICS INC is calculated as follows: GP [ $ 188.25M ] / Assets [ $ 692.22M ]
(=) GPA [ 27.19% ]

TVTX - Gross Profits to Assets, Last 5 years

16.96%

Minimum

Dec 31, 2023

58.25%

Maximum

Jun 30, 2025

30.77%

Average

28.3%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.15% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.15%
median15.35%
std19.95%